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Table 3
Progression
group n¼40
Non-progression
group n¼40 p value
Chromium, mg/L 0.0937  0.0325 0.0797  0.0287 0.045
Mangane, mg/L 0.0202  0.0080 0.0269  0.0078 0.600
Iron, mg/L 2.535  1.171 2.408  0.652 0.550
Copper, mg/L 1.074  0.374 1.287  0.369 0.013
Zinc, mg/L 0.241  0.205 0.230  0.138 0.796
Selenium, mg/L 0.0438  0.151 0.0368  0.0104 0.019
Trace elements between groups Data are expressed as mean  SD or median for normally
distributed data
Baseline characteristics of patients
Low syntax group
(SS < 13)
n¼252
High syntax group
(SS  13)
n¼151 p value
Age (year) 6313 6611 0.021
Sex (male) 166 (%66) 100 (%66) 0.942
Hypertension (%) 125 (%50) 74 (%49) 0.908
Diabetes mellitus (%) 66 (%26) 60 (%40) 0.005
Current smoker (%) 91 (%36) 49 (%32) 0.455
SBP (mmhg) 13217 13418 0.205
DBP (mmhg) 8610 8611 0.881
BMI (kg/m2) 273 263 0.852
LVEF on admission (%) 539 5110 0.008
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Aım: Bilirubin is an antioxidant that protect against atherosclerosis, moreover there is
an inversely relation between its levels and stable coronary artery disease under
normal conditions. Contrarily, Heme oxygenase (HO)-1 enyzme activity and its end
product bilirubin levels were elevated in body with acute stress as myocardial
infarction. In a previous study, high serum total bilirubin (sTB) levels were associated
with severity of disease in patients with ST elevation myocardial infarction (STEMI)
and also recent studies showed that relation between sTB levels and short-term
outcomes but not long-term outcome in STEMI patients. The association between sTB
and non-STEMI (NSTEMI) is unknown. The aim of this study to evaluated the
relation of sTB levels and severity of atherosclerosis and in patients with NSTEMI.
And also we evaluated to determine whether the sTB level on admission is a inde-
pendent predictor of all-cause mortality in patients with NSTEMI.
Methods:We admitted 403 consecutive patients with NSTEMI who were admitted to
the emergency department of our hospital from March 2010 to December 2012.
Selective coronary angiography was performed in multiple orthogonal views using
standard techniques. The SXscore was calculated using dedicated software that inte-
grates the number of lesions with their speciﬁc weighting factors based on the amount
of myocardium distal to the lesion according to the score of Leaman and colleagues
and the morphologic features of each single lesion, as previously reported. The study
population was divided into tertiles according to the SXscore. High syntax group
(n¼151) was deﬁned as a value in the third tertile (Sxscore 13), and low syntax
group (n¼252), as a value in the lower 2 tertiles (SXscore<13). The mortality data
was obtained from the hospital records or by interviewing (directly or by telephone)
the patients, their families, or their personal physicians. In all patients, antecubital
venous blood samples for laboratory analysis were drawn on admission to the
emergency room.
Results: Total bilirubin levels were signiﬁcantly higher in high syntax group
(0.590.17 vs. 0.650.21, p¼0.001).A signiﬁcant correlation detected between sTB
levels and syntax score (r¼0.495, p¼0.005). At multivariate analysis, total bilirubin
independent risk factor of high syntax score in patients with NSTEMI (b¼0.171,
SE¼2.158, p¼0.005). The mean follow-up period was 18.1 months. No differences
were seen in the all cause mortality rates between the high and low bilirubin groups.
Conclusıons: A total bilirubin level on admission is independently associated with
high syntax score in patients with NSTEMI. However, no association was found with
all cause mortality.Killip I (%) 187 (%74) 107 (%71) 0.464
Killip II (%) 65 (%26) 44 (%29) 0.464
Acute treatment
PCI (%) 218 (%87) 91(%60) <0.001
CABG surgery (%) 10 (%3) 50 (%33) <0.001
Medical (%) 24 (%10) 10 (%7) <0.001
Data are expressed as mean  SD or median for normally distributed data and percentage
(%) for categorical variables. SBP: Systolic blood pressure, DBP: Diastolic Blood Pressure, BMI:
Body mass index, LVEF: Left ventricular ejection fraction, PCI: Percutaneous coronary inter-
vention, CABG: Coronary artery bypass graft.
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Laboratory parameters of patients
Low syntax group
(SS < 13)
n¼252
High syntax group
(SS  13)
n¼151 p value
Glucose (mg/dL) 13246 14053 0.114
Creatinine (mg/dL) 0.960.21 1.020.25 0.004
LDL-C (mg/dL) 10821 11320 0.018
HDL-C (mg/dL) 388 389 0.912
Total cholesterol (mg/dL) 18641 17941 0.101
Triglycerides (mg/dL) 14966 13256 0.008
Total bilirubin (mg/dL) 0.590.17 0.650.21 0.001
Direct bilirubin (mg/dL) 0.200.07 0.220.08 0.017
LDH (u/L) 326102 334109 0.487
AST (u/L) 3819 3920 0.691
ALT (u/L) 2712 2713 0.872
GGT (u/L) 3016 3520 0.009
White blood cell (x109/L) 9.533.18 10.033.58 0.145
Hemoglobin (g/L) 13.92.1 13.72.0 0.365
Hs-CRP (mg/l) 19.513.1 25.724.1 0.006
Troponin-I (ng/mL) 2.750.93 3.451.22 0.155
CK-MB (U/L) 5127 5427 0.717
Data are expressed as mean  SD or median for normally distributed data and percentage
(%) for categorical variables. SS: Syntax score, LDL-C: Low density lipoprotein cholesterol, HDL-
C: High density lipoprotein cholesterol, LDH: Lactate dehydrogenase, AST: Aspartate amino
transferase ALT: Alanine amino transferase, GGT: Gamma glutamyl transferase, Hs-CRP: High
sensitivity C-reactive protein, CK-MB: Peak creatine kinase-MB
Effects of various variables on high syntax score in multivariate linear
regression analyses
Variables* b SE p value
Age 0.100 0.027 0.041
DM 0.090 0.713 0.064
Total bilirubin 0.171 2.158 0.005
LDL-C 0.121 0.016 0.014
CRP 0.096 0.015 0.052
Troponin-I 0.124 0.069 0.011
*Adjusted for Age, DM, Total bilirubin, LDL-C, CRP and Troponin-T. DM: Diabetes mellitus, LDL-
C: Low density lipoprotein cholesterol, CRP: C-reactive protein.
Multivariate cox regression analyses of patients for all cause mortality
Risk factors HR (95% CI) p value
High syntax score 1.59 (1.25-2.04) <0.001
Troponin I 1.06 (1.03-1.08) <0.001
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Objectıve: Cardiac syndrome X (CSX) is a clinical entity characterized with typical
exertional angina and myocardial ischemia shown by ECG or metabolically and
normal epicardial coronary anjiogram without inducible vasospasm, of which
underlying pathophysiological mechanisms are not well underrstood yet. Diabetes
mellitus (DM) is an important risk factor for CSX development as it is for the
obstructive coronary artery disease. But the question 'why some diabetic patients
develop CSX while others not?' has not been answered yet. There are many papers
suggesting hipercoagulability and endothelial dysfunction development in patients
with DM.The aim of this study is to investigate whether plasma levels of coagulation
factors XI (F XI) and XII (F XII) which take part in the intrinsic coagulation pathway
working independent of endothelium play a role in the development of CSX in
patients with DM.C218 JACC VoMethod: CSX diagnosis was done by the presence of exertional angina and
myocardial ischemia shown by ECG or scintigraphy and normal or near normal
epicardial coronary arteries without inducible coronary vasospasm. There are 72
patients diagnosed as CSX between june'11 and may'12 of which 48 known diabetics
and two newly diagnosed diabetics were included to study group consisted of 50
patients. Control group was planned as 45 patients with DM who has no ischemia was
shown by noninvasive tests. 11 patients refused to take part in the study so they were
excluded and rest 34 patients formed the control group.
Results: Both of the coagulation factors XI and XII were higher in the CSX group in
comparison with controls (respectively 129.923.3 IU/dL vs 118.219.4 IU/dL,
p¼0.019*; 106.525.6 vs 99.123.7 IU/dL, p¼0.187).Only high plasma levels of
FXI was statistically signiﬁcant. There was no difference between CSX and control
group in terms of age, sex, body mass index (BMI), smoking, HT, and the time since
diagnosis of DM. Plasma levels of LDL and total cholesterol was higher in the control
group compared to patients,and the rest of laboratory values were similar between
groups including HgA1c level. Even F XI and F XII levels were not related with
smoking, BMI, time since DM diagnosis,and HgA1c levels.
Conclusıon: The results of this study showed that the intrinsic coagulation pathway is
more active in diabetic patients who developed CSX when compared to diabetics
without CSX. This study may provide some data for the researchers seeking for the
role of hipercoagulability in the development of CSX.
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Purpose: In order to assess systemic inﬂammation activity depending on the meta-
bolic status and occupational inﬂuence of xenobiotic 96 patients with myocardial
infarction aged 20-64 yy were assessed.
Methods: State of the lipid, carbohydrate, purine metabolism, body mass ratio, hair
composition of 28 elements, blood levels of c-reactive protein, total ﬁbrinogen, tumor
necrosis factor-a were evaluated. Patients were randomized into 2 groups: 1st group
(I) included patients who had occupational contact with xenobiotics, 2nd (II) –
patients who had no contact with xenobiotics, control – 25 healthy subjects.
Results: Myocardial infarction in 1st group patients under 50 y.o. develops
predominantly on the background of normal values of lipid, carbohydrate, purine
metabolism, low incidence of traditional cardiovascular risk factors and high activity
of systemic inﬂammation evidenced by reliably higher levels of c-reactive protein
(8,230,45 (I); 6,520,58 (II) (mg/l), p<0,05) and total ﬁbrinogen (4,140,11 (_);
3,410,12 (__) (g/l), p<0,05), compared to control and 2nd group. Regardless of
occupation, higher mean level of c-reactive protein prevailed in patients younger than
50. Mean level of tumor necrosis factor-a was higher in older age (over 51) and
prevailed in 2nd group what may be related to higher incidence of metabolic disorders
(atherogenic dyslipidemia, overweight, diabetes mellitus, etc. (48,907,16 (_);
85,2415,66 (pg/ml), p<0,01 (__)). C-reactive protein and ﬁbrinogen levels correlated
with hair and plasma concentration of heavy metals: manganese, zinc, nickel, cobalt,
cadmium, lead, strontium (r¼0,484-0,990, p<0,01). Tumor necrosis factor-a analysis
conﬁrmed its strong relation with metabolic values: elevation of glycated hemoglobin,
low density cholesterol, apolipoprotein-B.
Conclusion: Among patients younger than 50 who had occupational contact with
xenobiotics myocardial infarction development is associated with high activity of
systemic inﬂammation. Xenobiotics are capable to cause systemic inﬂammation and
endothelial dysfunction, induce cytokine and acute phase proteins, resulting in acute
coronary circulatory disorders even in absence of severe metabolic disorders.
Continuous contact with technogeneous chemical substances causes more intense
inﬂuence on c-reactive protein and ﬁbrinogen elevation, metabolic disorders – on
tumor necrosis factor-a. Combination of continuous occupational contact with
xenobiotics with metabolic disorders results in reciprocal enhancement of proin-
ﬂammatory effects and complicated duration of myocardial infarction.
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Background: Coronary artery disease is one of the leading causes of mortality
worldwide. The diagonal ear lobe crease (ELC) has been recommended as a simple,
noninvasive marker of cardiovascular diseases. Epicardial adipose tissue (EAT)
thickness and carotid intima media thickness (CIMT) are closely related to cardio-
vascular disorders and atherosclerosis. There is no knowledge abaout the relation
between EAT thickness, CIMT and diagonal ELC. The aim of our study is to evaluate
the association between EAT thickness, CIMT and ELC.
Method: Study population was selected from apparently healthy individuals who
were refered to hospital for a standard checkup. Sixty ﬁve subjects with ELC and sixtyl 62/18/Suppl C j October 26–29, 2013 j TSC Abstracts/POSTERS
